Resources
14 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 12/20/2021 (updated 3/26/2024)
The Centers for Disease Control and Prevention (CDC) want greater awareness of adverse childhood experiences (ACEs) and their connection to high rates of overdose and suicide. This week they announced a new training webpage, UrgentRelatedPreventable.org, designed in collaboration with the American Public Health Association to provide background and talking points. The site explains how exposure to certain events and conditions in childhood have lasting effects on health, well-being, and prosperity far into adulthood. See Funding section below for a CDC effort to research the links between ACEs and substance use.
Posted 4/20/2022 (updated 3/27/2024)
The Substance Abuse and Mental Health Services Administration-funded Opioid Response Network (ORN) initiative has launched the Stand Against Stigma (SAS) Challenge. This is an opportunity for those in the healthcare industry to address and dispel stigma related to individuals with substance use disorders through easy, daily activity.
Posted 10/10/2023 (updated 3/27/2024)
The University of Rochester, a RCORP-Rural Center of Excellence on SUD Prevention, has 988 Lifeline posters available for download on their website. The national 988 Suicide & Crisis Lifeline was launched in July 2023 and provides a way for individuals experiencing a suicidal, mental health, or substance use disorder crisis to receive urgent help 24/7. Spreading awareness of the 988 Lifeline is important as it can help residents in rural areas obtain treatment and help quickly.
Posted 8/17/2022 (updated 3/27/2024)
This presentation will detail the efforts behind the grant to develop a Recovery Friendly Workplace credential through training, technical assistance, and support that assists businesses in fostering a workplace culture that promotes employee safety, health, and well-being.
Posted 12/21/2022 (updated 3/27/2024)
The Substance Abuse and Mental Health Services Administration released a notice of proposed rulemaking that would allow certified opioid treatment programs to begin prescribing the drug via audio-only or video-enabled telehealth. See additional information under Policy Updates below. The proposed changes come on top of recent findings by HHS of the positive impact of its revised Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder that removed two longstanding requirements for obtaining a waiver to treat up to 30 patients with buprenorphine: 1) the requirement for specific training, and 2) the need for otherwise eligible clinicians to certify their ability to provide or refer patients for counseling and other services. Rural primary care providers have obtained the DEA waiver at a lower rate than urban clinicians; decreased burden and greater flexibility in the guidelines, along with broader use of telehealth could help close that gap.
Posted 11/28/2023 (updated 3/28/2024)
Substance use is a major health issue among individuals in custody, and for these individuals, withdrawal from substances can be life-threatening. Jurisdictions have a pressing responsibility to save lives by implementing policies and protocol that align with legal, regulatory, and clinical standards related to appropriate withdrawal management. Recently released Guidelines for Managing Substance Withdrawal in Jails sets forth best clinical practices and actionable guidance for jails. This presentation discussed readiness for implementation, key components of implementation, and solutions for implementation in local communities and jails.
Learning Objectives:
-Assessed readiness for implementing a comprehensive and appropriate multidisciplinary approach to withdrawal management.
-Discussed action steps for building community support.
-Identified resources for training and technical assistance to implement the Guidelines.
Presenter:
Linda J. Frazier, B.S, M.A., RN, MCHES
Principal Consultant, Advocate for Human Potential, Inc.
Posted 2/13/2024 (updated 3/28/2024)
Dr. Ashli Sheidow will discuss this age group and some of the considerations for designing services for them, especially within a rural context.
Posted 4/3/2020 (updated 3/28/2024)
This RSV plenary session was held in the Independence Ballroom on Wednesday, March 5, 2020, at 4:00 PM
Posted 8/4/2021 (updated 4/2/2024)
Posted 8/19/2021 (updated 4/2/2024)
Addiction Policy Forum, in partnership with Justice Community Opioid Innovation Network (JCOIN) and the National Judicial Task Force to Examine State Courts’ Response to Mental Illness, have released a new online course to help educate judges and court staff on the FDA-approved medications to treat opioid use disorder and their effectiveness for people involved with the criminal justice system.
The course is self-paced and takes approximately 30 minutes to complete. The course aims to prepare participants with the knowledge and information about what substance use disorder treatment involves, the differences between the types of medications used to treat opioid use disorder, and how those medications work.